Pulmonary Medicine

Significant Accomplishments

Lung Transplant Program to Begin in Spring 2014

In collaboration with the Heart Institute, we are developing Cincinnati’s first Lung Transplant Program. We anticipate beginning lung transplants and lung-heart transplants by spring 2014.

Upper-Airway Center Established

Our newly established Upper-Airway Center is a multidisciplinary program that includes expertise from Pulmonology, Human Genetics, Plastic Surgery, Radiology , the ENT Outpatient Treatment Center and the Jane and Richard Thomas Center for Down Syndrome. The Center provides additional assessment and innovative care for patients with persistent upper-airway obstruction after receiving standard therapy.

No. 2 in the Nation

We were ranked No. 2 in the nation for Pulmonology by US News & World Report for the second year in a row, with an overall score of 96.8 out of 100. We received “superior” rankings in more than half of the categories judged, including asthma-management success, commitment to best practices and quality improvement, and efforts to involve families.

New faculty bring research, clinical strength

Jason Woods, PhD, has been appointed Director of the Center for Pulmonary Imaging Research, a multidisciplinary research and training program between Pulmonary Medicine and Radiology. Woods is one of the world’s leading experts on using  hyperpolarized-gas MRI to measure regional lung function, microstructure, and physiology.  Woods is the academic principal investigator for an NIH-funded study entitled, “Single-session bronchial thermoplasty for severe asthmatics guided by HXe MRI.” This project will quantify regional ventilation abnormalities in patients with severe asthma and evaluate the outcomes of using image guidance to reduce risk to patients receiving bronchial thermoplasty.

Anjaparavanda Naren, PhD, has joined our faculty to continue his research of the structural and functional aspects of cystic fibrosis transmembrane conductance regulator (CFTR) ion-channel biology. His work includes developing and exploring the therapeutic potential of reagents used to augment the current activity of CFTR mutants, understanding the physical and functional coupling of the channel (CFTR) to the receptor (beta 2AR and LPA2) and its relevance to CFTR-dysfunction diseases, and defining a role for CFTR and t-SNARE (syntaxin 1A and SNAP23) interaction in vesicular translocation.

Satish Madala, PhD, was promoted to Assistant Professor. He also  was awarded a Parker B. Francis Fellowship to initiate his independent research program entitled, “Molecular Mechanisms of TGFα-driven Pulmonary Fibrosis.” His other research interests include using transgenic and non-transgenic mouse models to identify cellular and molecular mechanisms of fibrotic diseases including idiopathic pulmonary fibrosis, cystic fibrosis and scleroderma.